Drug Desensitization Market, By Type (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), By End-Users, By Sales Channel, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4718
|
Published Date
February 2026
|
Pages
328
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Drug Desensitization Market size was valued at US$ 602.10 Million in 2024, expanding at a CAGR of 8.07% from 2025 to 2032.
The drug desensitization market encompasses therapeutic interventions and structured clinical protocols designed to temporarily increase patient tolerance to critical medications in individuals with known hypersensitivity or allergic reactions, enabling them to safely continue essential treatments under controlled healthcare conditions. Market growth is being driven by the rising prevalence of drug allergies — globally, adverse drug reactions may affect up to 10% of the world’s population and account for a significant share of hospital hypersensitivity cases — and by the increasing use of firstline therapies such as antibiotics, chemotherapy agents, and biologics for serious and lifethreatening conditions. Healthcare spending on prevention, diagnosis, treatment, and rehabilitation continues to rise worldwide, enabling greater investment in advanced diagnostics, personalized desensitization protocols, and patient monitoring technologies that support more precise and effective clinical strategies. A notable trend in the market is the shift toward personalized, protocolbased desensitization backed by cuttingedge diagnostic tools and realtime patient monitoring systems. However, the need for highly trained clinical personnel, intensive medical oversight, and high treatment costs remains a major constraint. Despite these challenges, increasing clinician awareness and the expanding use of biologics and oncology treatments are driving opportunities for broader implementation of standardized desensitization programs in hospitals and specialty care settings.
Drug Desensitization Market- Market Dynamics
Increasing Prevalence of Drug Hypersensitivity Reactions
The rising incidence of drug hypersensitivity reactions is a key factor driving global demand for drug desensitization therapies. As the pharmaceutical industry expands into new therapeutic areas, an increasing number of patients experience immune-mediated adverse reactions to essential medications, including antibiotics, chemotherapeutic agents, and biologics. These hypersensitivity reactions range widely in severity—from mild skin rashes to severe, life-threatening allergic responses—creating significant challenges for maintaining effective and continuous treatment. According to a March 2023 review titled “Pathogenesis of Allergic Diseases and Implications for Therapeutic Interventions”, drug hypersensitivity reactions account for approximately 5–10% of all adverse drug reactions, affecting 7–10% of the global population. While self-reported drug allergies occur in about 8% of individuals, confirmed cases are considerably lower. Among pediatric populations, suspected hypersensitivity reactions affect 1–2%, with confirmed cases around 0.05%. Antibiotics remain the most common triggers, responsible for nearly 30% of severe reactions, including conditions such as Stevens–Johnson syndrome.
Drug Desensitization Market- Segmentation Analysis:
The worldwide market is segmented on the basis of Type, End-Users, Sales Channel, and Region.
By Type, Sublingual Immunotherapy (SLIT) has emerged as the leading approach in the global drug desensitization market, projected to account for 66.1% of the market by 2025. The primary driver of this dominance is the patient-centered convenience of SLIT, which involves administering allergenic extracts or therapeutic agents under the tongue at home. This self-administered method reduces the need for frequent clinic visits, making treatment more comfortable, accessible, and adherence-friendly. Clinical outcomes further support its widespread adoption. In October 2023, the American Academy of Allergy, Asthma, and Immunology (AAAAI) reported that SLIT led to 60% desensitization and 48% remission in peanut-allergic children over three years, with early intervention in childhood proving crucial for long-term allergy remission. Globally, governments are recognizing the public health importance of allergy management: the World Allergy Organization estimates that over 20% of the population worldwide suffers from allergic diseases, prompting more than 50 countries to integrate immunotherapy and allergy desensitization programs into national healthcare policies and funding initiatives.
By End User, hospitals and specialized allergy clinics remain the dominant segment in the drug desensitization market. These facilities combine advanced diagnostic tools, specialized clinical expertise, and multidisciplinary patient management to deliver safe, evidence-based treatments in controlled healthcare settings. They are particularly well-equipped to perform complex drug desensitization procedures using individualized dosing protocols, continuous patient monitoring, and close supervision by immunologists and allergy specialists. Regulatory approvals underscore the critical role of hospitals and specialty clinics in this segment. For example, in February 2024, the U.S. Food and Drug Administration approved Xolair (omalizumab), developed by Genentech and Novartis, as the first therapy shown to reduce allergic reactions to multiple foods after accidental exposure. The approval extends to adults and children aged one year and older with IgE-mediated food allergies, highlighting the need for professional oversight in administering advanced desensitization treatments. Supporting this global trend, the WHO reports that over 80% of high- and middle-income countries have established hospital-based immunotherapy programs to manage complex allergic conditions, emphasizing the institutional reliance on hospitals and specialty clinics for safe and effective allergy care.
Drug Desensitization Market- Geographical Insights
North America is a key region in the global drug desensitization market in 2025, driven by its advanced healthcare infrastructure, a strong presence of pharmaceutical and biotechnology companies, and supportive government policies that foster innovation in allergy management and immune tolerance therapies. The region also benefits from significant public and private investments in research and development, which continue to advance therapeutic innovations and clinical adoption. For instance, in September 2025, ARS Pharmaceuticals, a U.S.-based biopharmaceutical company, received regulatory approval in Japan for Neffy, the first and only needle-free epinephrine nasal spray for the emergency treatment of allergic reactions and anaphylaxis. Developed in collaboration with Alfresa Holdings, which will commercialize the product in Japan, Neffy is expected to be available in the fourth quarter of 2025 for adults and pediatric patients weighing more than 15 kilograms.
United States Drug Desensitization Market- Country Insights
The U.S. drug desensitization market remains the largest globally, driven by substantial investments in research and development, advanced healthcare infrastructure, and a high prevalence of drug and food sensitivities among patients. The presence of leading pharmaceutical companies, including Regeneron Pharmaceuticals and Horizon Therapeutics, along with well-established specialized allergy treatment centers, is accelerating the adoption of advanced desensitization protocols nationwide. For example, in September 2023, Nestlé divested its peanut allergy treatment Palforzia to U.S.-based Stallergenes Greer, a recognized leader in allergen immunotherapy and drug desensitization. Palforzia, the first oral therapy approved by the U.S. FDA for peanut allergy, was originally acquired by Nestlé in 2020 for USD 2.1 billion but had limited commercial uptake. This acquisition positioned Stallergenes Greer as the first company to offer therapies for both respiratory and food allergies, while allowing Nestlé to realign its strategic focus on gastrointestinal treatments.
Drug Desensitization Market- Competitive Landscape:
The drug desensitization market is moderately consolidated, comprising established pharmaceutical companies, specialized allergy therapy providers, and emerging biotech firms focused on immunology and hypersensitivity management. Market participants compete by developing innovative products, expanding clinical indications, and forming strategic alliances with hospitals and specialty allergy clinics. Companies are increasingly investing in research and development to enhance desensitization protocols, improve patient safety, and broaden applications for drug, food, and biologic allergies. Regulatory approvals and strategic acquisitions remain key approaches for strengthening market positioning and expanding product portfolios. Leading players include ALK-AbellA/S, HollisterStier Allergy (Jubilant Pharma), All Cure Pharma Pvt Ltd, and Allergopharma GmbH & Co. KG, all of which leverage clinical expertise and global distribution networks to maintain a competitive edge and drive growth.
Recent Developments:
-
In February 2025, ALK-AbellA/S, a Danish specialty pharmaceutical company focusing on allergy immunotherapy and allergic asthma, received FDA approval for its DACTRAtablet to treat house dust mite-induced allergic rhinitis in children aged five to eleven. This approval expands on its existing clearance for patients aged twelve to sixty-five, reinforcing ALK’s leadership in drug desensitization therapies.
-
In January 2025, Stallergenes Greer, a Swiss biopharmaceutical company specializing in allergen immunotherapy, received European Commission approval to extend Palforzia for treating toddlers aged one to three with confirmed peanut allergies. As the first oral drug desensitization therapy approved by both the EMA and FDA for this age group, Palforzia promotes tolerance to peanut allergens and reduces the risk of severe allergic reactions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG DESENSITIZATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- IDEXX Laboratories Inc
- ALK-Abello A/S
- HollisterStier Allergy (Jubilant Pharma)
- All Cure Pharma Pvt Ltd
- Allergopharma GmbH and Co KG
- HAL Allergy Group
- LETI Pharma
- Torii Pharmaceutical Co Ltd
- Inmunotek S.L.
- Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
- DBV Technologies SA
- Prota Therapeutics Pty Ltd
- Stallergenes Greer
- Allergy Therapeutics pIc
- Aimmune Therapeutics Inc
- Others
GLOBAL DRUG DESENSITIZATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Other emerging immunotherapy delivery methods
GLOBAL DRUG DESENSITIZATION MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032
- Outpatient treatment centers
- Hospitals and specialty allergy clinics
- Homecare settings
- Others
GLOBAL DRUG DESENSITIZATION MARKET, BY SALES CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Online Channel
- Offline Channel
GLOBAL DRUG DESENSITIZATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Drug Desensitization Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Drug Desensitization Market Snippet by Type
2.1.2. Drug Desensitization Market Snippet by End-Users
2.1.3. Drug Desensitization Market Snippet by Sales Channel
2.1.4. Drug Desensitization Market Snippet by Country
2.1.5. Drug Desensitization Market Snippet by Region
2.2. Competitive Insights
3. Drug Desensitization Key Market Trends
3.1. Drug Desensitization Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Drug Desensitization Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Drug Desensitization Market Opportunities
3.4. Drug Desensitization Market Future Trends
4. Drug Desensitization Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Drug Desensitization Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Drug Desensitization Market Landscape
6.1. Drug Desensitization Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Drug Desensitization Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Subcutaneous Immunotherapy (SCIT)
7.1.3. Sublingual Immunotherapy (SLIT)
7.1.4. Other emerging immunotherapy delivery methods
8. Drug Desensitization Market – By End-Users
8.1. Overview
8.1.1. Segment Share Analysis, By End-Users, 2024 & 2032 (%)
8.1.2. Outpatient treatment centers
8.1.3. Hospitals and specialty allergy clinics
8.1.4. Homecare settings
8.1.5. Others
9. Drug Desensitization Market – By Sales Channel
9.1. Overview
9.1.1. Segment Share Analysis, By Sales Channel, 2024 & 2032 (%)
9.1.2. Online Channel
9.1.3. Offline Channel
10. Drug Desensitization Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Drug Desensitization Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Drug Desensitization Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Drug Desensitization Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Drug Desensitization Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Drug Desensitization Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Sales Channel, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Drug Desensitization Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. IDEXX Laboratories Inc
11.2.2. ALK-Abello A/S
11.2.3. HollisterStier Allergy (Jubilant Pharma)
11.2.4. All Cure Pharma Pvt Ltd
11.2.5. Allergopharma GmbH and Co KG
11.2.6. HAL Allergy Group
11.2.7. LETI Pharma
11.2.8. Torii Pharmaceutical Co Ltd
11.2.9. Inmunotek S.L.
11.2.10. Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
11.2.11. DBV Technologies SA
11.2.12. Prota Therapeutics Pty Ltd
11.2.13. Stallergenes Greer
11.2.14. Allergy Therapeutics pIc
11.2.15. Aimmune Therapeutics Inc
11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DRUG DESENSITIZATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- IDEXX Laboratories Inc
- ALK-Abello A/S
- HollisterStier Allergy (Jubilant Pharma)
- All Cure Pharma Pvt Ltd
- Allergopharma GmbH and Co KG
- HAL Allergy Group
- LETI Pharma
- Torii Pharmaceutical Co Ltd
- Inmunotek S.L.
- Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
- DBV Technologies SA
- Prota Therapeutics Pty Ltd
- Stallergenes Greer
- Allergy Therapeutics pIc
- Aimmune Therapeutics Inc
- Others
GLOBAL DRUG DESENSITIZATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Other emerging immunotherapy delivery methods
GLOBAL DRUG DESENSITIZATION MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032
- Outpatient treatment centers
- Hospitals and specialty allergy clinics
- Homecare settings
- Others
GLOBAL DRUG DESENSITIZATION MARKET, BY SALES CHANNEL- MARKET ANALYSIS, 2019 - 2032
- Online Channel
- Offline Channel
GLOBAL DRUG DESENSITIZATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
